- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT07613242
Multimodal Assisted Diagnosis for Pediatric Respiratory Diseases Using Questionnaires, Cough Sounds, and Breath Sounds
A Prospective Observational Study of Multimodal Assisted Diagnosis for Pediatric Respiratory Diseases Using Symptom Questionnaires, Cough Sounds, and Breath Sounds
Studieoversikt
Status
Intervensjon / Behandling
Detaljert beskrivelse
Studietype
Registrering (Antatt)
Kontakter og plasseringer
Studiekontakt
- Navn: Yong Yin
- Telefonnummer: +83015 86-021-38626161
- E-post: yinyong9999@163.com
Studiesteder
-
-
Shanghai Municipality
-
Shanghai, Shanghai Municipality, Kina, 200127
- Shanghai Children's Medical Center
-
Ta kontakt med:
- Yong Yin
- Telefonnummer: +83015 86-021-38626161
- E-post: yinyong9999@163.com
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
- Barn
- Voksen
Tar imot friske frivillige
Prøvetakingsmetode
Studiepopulasjon
Beskrivelse
Inclusion Criteria:
Children aged 28 days to 18 years, regardless of sex, will be eligible for inclusion. The disease group will include children presenting to the outpatient department, emergency department, or inpatient wards of Shanghai Children's Medical Center with cough, wheezing, fever with respiratory symptoms, nasal congestion, rhinorrhea, sore throat, or other respiratory complaints. Participants should be able to complete the symptom questionnaire, cough sound recording, and breath sound recording, and their guardians must provide informed consent and allow review of relevant medical history and diagnostic information. The healthy control group will include children recruited from routine health examinations or children without respiratory complaints, with no acute respiratory symptoms within the past 4 weeks, no known history of chronic respiratory diseases, no obvious respiratory abnormalities on health assessment or research team review, the ability to complete relevant data collection, and guardian informed consent.
Exclusion Criteria:
Participants will be excluded if they have severe cardiopulmonary malformations, long-term tracheostomy or mechanical ventilation, severe neuromuscular disorders, severe immunodeficiency, or other conditions that may substantially alter cough sound characteristics or affect the clinical presentation of respiratory diseases. Children whose primary diagnosis at the current visit is a non-respiratory disease and who are not suitable for this study will also be excluded. Participants who are unable to complete the symptom questionnaire, or whose cough sound or breath sound recordings remain of insufficient quality after repeated attempts, will not be included or will be excluded from the corresponding modality-specific analysis. Participants with only one unavailable modality may be included in analyses based on the completed modalities but will be excluded from analyses requiring the missing modality. Healthy controls will be excluded from the main control analysis if recent respiratory symptoms, a history of chronic respiratory disease, or other conditions that may affect acoustic features are identified.
Studieplan
Hvordan er studiet utformet?
Designdetaljer
Kohorter og intervensjoner
Gruppe / Kohort |
Intervensjon / Behandling |
|---|---|
|
Children with respiratory complaints
Children aged 28 days to 18 years presenting with cough, wheezing, fever with respiratory symptoms, nasal congestion, rhinorrhea, sore throat, or other respiratory complaints.
|
Participants will complete a structured symptom questionnaire, cough sound recording using a smartphone application, and breath sound recording using an electronic stethoscope.
These data will be used to develop and evaluate a multimodal assisted diagnostic model and will not guide real-time clinical decision-making.
|
|
Healthy controls
Children aged 28 days to 18 years recruited from routine health examinations or without respiratory complaints, with no acute respiratory symptoms within the past 4 weeks and no known chronic respiratory disease.
|
Participants will complete a structured symptom questionnaire, cough sound recording using a smartphone application, and breath sound recording using an electronic stethoscope.
These data will be used to develop and evaluate a multimodal assisted diagnostic model and will not guide real-time clinical decision-making.
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Area under the receiver operating characteristic curve of the multimodal assisted diagnostic model
Tidsramme: Through study completion, an average of 1 year
|
The area under the receiver operating characteristic curve will be used to evaluate the diagnostic performance of the multimodal assisted diagnostic model integrating symptom questionnaire, cough sound, and breath sound data.
The model will be assessed against the final clinical research label for distinguishing children with respiratory diseases from healthy controls and for identifying major pediatric respiratory disease categories.
|
Through study completion, an average of 1 year
|
|
Area under the precision-recall curve of the multimodal assisted diagnostic model
Tidsramme: Through study completion, an average of 1 year
|
The area under the precision-recall curve will be used to evaluate the diagnostic performance of the multimodal assisted diagnostic model, particularly in settings with imbalanced disease categories.
The model will be assessed against the final clinical research label.
|
Through study completion, an average of 1 year
|
Sekundære resultatmål
Resultatmål |
Tidsramme |
|---|---|
|
Sensitivity of the multimodal assisted diagnostic model
Tidsramme: Through study completion, an average of 1 year
|
Through study completion, an average of 1 year
|
|
Specificity of the multimodal assisted diagnostic model
Tidsramme: Through study completion, an average of 1 year
|
Through study completion, an average of 1 year
|
|
Positive predictive value of the multimodal assisted diagnostic model
Tidsramme: Through study completion, an average of 1 year
|
Through study completion, an average of 1 year
|
|
Negative predictive value of the multimodal assisted diagnostic model
Tidsramme: Through study completion, an average of 1 year
|
Through study completion, an average of 1 year
|
|
F1 score of the multimodal assisted diagnostic model
Tidsramme: Through study completion, an average of 1 year
|
Through study completion, an average of 1 year
|
|
Accuracy of the multimodal assisted diagnostic model
Tidsramme: Through study completion, an average of 1 year
|
Through study completion, an average of 1 year
|
Samarbeidspartnere og etterforskere
Etterforskere
- Hovedetterforsker: Yong Yin, Shanghai Children's Medical Center
Studierekorddatoer
Studer hoveddatoer
Studiestart (Antatt)
Primær fullføring (Antatt)
Studiet fullført (Antatt)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Faktiske)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Ytterligere relevante MeSH-vilkår
- Patologiske prosesser
- Sykdommer i immunsystemet
- Luftveisinfeksjoner
- Infeksjoner
- Sykdommer i luftveiene
- Lungesykdommer
- Bronkiale sykdommer
- Lungesykdommer, obstruktiv
- Respiratorisk overfølsomhet
- Overfølsomhet, Umiddelbar
- Overfølsomhet
- Lungebetennelse
- Patologiske tilstander, tegn og symptomer
- Samfunnservervede infeksjoner
- Astma
- Sykdom
- Samfunnservervet lungebetennelse
Andre studie-ID-numre
- SCMCIRB-YJ20260516
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Studerer et amerikansk FDA-regulert enhetsprodukt
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .
Kliniske studier på Community-ervervet lungebetennelse (CAP)
-
Capital Medical UniversityChina-Japan Friendship Hospital; Beijing Municipal Health CommissionHar ikke rekruttert ennåCommunity Acquired Pneumonia (CAP)Kina
-
University of Maryland, BaltimoreHar ikke rekruttert ennåCommunity Acquired Pneumonia (CAP)Forente stater
-
Sohag UniversityHar ikke rekruttert ennåCommunity Acquired Pneumonia (CAP)
-
Ann & Robert H Lurie Children's Hospital of ChicagoPatient-Centered Outcomes Research InstituteRekrutteringSamfunnservervet lungebetennelse | Community Acquired Pneumonia (CAP)Forente stater
-
Children's Hospital of PhiladelphiaPatient-Centered Outcomes Research InstituteAktiv, ikke rekrutterendeBihulebetennelse | Community Acquired Pneumonia (CAP) | Akutt mellomørebetennelse (AOM) | Strep faryngittForente stater
-
PfizerFullførtCommunity Acquired Pneumonia (CAP)Spania
-
PfizerFullførtCommunity Acquired Pneumonia (CAP)Japan
-
Copenhagen Respiratory ResearchHar ikke rekruttert ennåCommunity Acquired Pneumonia (CAP)
-
Copenhagen Respiratory ResearchRekrutteringCommunity Acquired Pneumonia (CAP)Danmark
-
Societa Italiana di PneumologiaRekrutteringCommunity Acquired Pneumonia (CAP)Italia